Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Geriatr Gerontol Int ; 10 Suppl 1: S99-106, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20590847

RESUMO

The effects of acetyl-L-carnitine (ALCAR), an acetyl derivative of L-carnitine, on memory and learning capacity and on brain synaptic functions of aged rats were examined. Male Fischer 344 rats were given ALCAR (100 mg/kg bodyweight) per os for 3 months and were subjected to the Hebb-Williams tasks and AKON-1 task to assess their learning capacity. Cholinergic activities were determined with synaptosomes isolated from brain cortices of the rats. Choline parameters, the high-affinity choline uptake, acetylcholine (ACh) synthesis and depolarization-evoked ACh release were all enhanced in the ALCAR group. An increment of depolarization-induced calcium ion influx into synaptosomes was also evident in rats given ALCAR. Electrophysiological studies using hippocampus slices indicated that the excitatory postsynaptic potential slope and population spike size were both increased in ALCAR-treated rats. These results indicate that ALCAR increases synaptic neurotransmission in the brain and consequently improves learning capacity in aging rats.


Assuntos
Acetilcarnitina/farmacologia , Encéfalo/efeitos dos fármacos , Complexo Vitamínico B/farmacologia , Envelhecimento/fisiologia , Animais , Carnitina/análise , Hipocampo/química , Hipocampo/metabolismo , Aprendizagem/efeitos dos fármacos , Masculino , Aprendizagem em Labirinto , Memória/efeitos dos fármacos , Músculo Esquelético/química , Miocárdio/química , Ratos , Ratos Endogâmicos F344 , Transmissão Sináptica/efeitos dos fármacos , Sinaptossomos/química
2.
Neurochem Res ; 28(1): 5-13, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12587659

RESUMO

Turnover rates of myelin membrane components in mouse brains were determined by a method using stable isotope-labeling and mass spectrometry. The half-replacement times based on incorporation rates of newly synthesized molecules for young adult mice were 359 days for cholesterol, 20 days for phosphatidylcholine, 25 days for phosphatidylethanolamine, 94 days for cerebroside and 102 days for ganglioside GM1. The turnover rates of half-lives of myelin components were calculated from the decay curves of initially labeled molecules, and they were about the same as the half-replacement times. Individual components were thus revealed to be metabolized at different rates, and their turnover rates were differently affected by aging. As was observed with phospholipids, myelin pools appeared to be compartmentalized into rapidly and slowly exchanging pools. The turnover rates of cerebroside and GM1 decreased between the young and adult periods and slightly increased in senescence. The latter phenomenon may indicate an enhanced myelin turnover in senescence. The present study reveals the dynamic aspects of myelin membrane turnover during the life span of mouse.


Assuntos
Envelhecimento/metabolismo , Encéfalo/metabolismo , Metabolismo dos Lipídeos , Bainha de Mielina/metabolismo , Animais , Meia-Vida , Camundongos , Camundongos Endogâmicos C57BL
3.
J Neurosci Res ; 70(3): 290-7, 2002 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-12391588

RESUMO

We examined age-related changes in the turnover rates of synaptic membrane components that might underlie the decrease in synaptic functions in senescence. Synaptic membrane constituents were labeled in vivo with deuterium and the disappearance of the deuterated molecules from synaptic membranes was measured by mass spectrometry. The turnover rates of phosphatidylcholine, phosphatidylethanolamine, cholesterol, and synaptophysin were all shown to slow down with aging. Dietary restriction, which is known to retard various aging processes, was found to decrease the turnover rates of membrane lipid species. Consequently, the fatty acid composition in phospholipids remained unchanged in the synaptic plasma membranes of food restricted mice. In contrast, the turnover rate of synaptophysin was accelerated under dietary restriction. This may mean that increased turnover enhances the removal of damaged proteins from membranes.


Assuntos
Envelhecimento/metabolismo , Encéfalo/metabolismo , Privação de Alimentos/fisiologia , Lipídeos de Membrana/metabolismo , Doenças Neurodegenerativas/metabolismo , Neurônios/metabolismo , Membranas Sinápticas/metabolismo , Animais , Encéfalo/fisiopatologia , Colesterol/metabolismo , Deutério , Ácidos Graxos/metabolismo , Camundongos , Doenças Neurodegenerativas/fisiopatologia , Fosfatidilcolinas/metabolismo , Fosfatidiletanolaminas/metabolismo , Sinaptofisina/metabolismo
4.
J Neurosci Res ; 70(3): 519-27, 2002 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-12391613

RESUMO

A rat dementia model with cognitive deficits was generated by synapse-specific lesions using botulinum neurotoxin (BoNTx) type B in the entorhinal cortex. To detect cognitive deficits, different tasks were needed depending upon the age of the model animals. Impaired learning and memory with lesions were observed in adult rats using the Hebb-Williams maze, AKON-1 maze and a continuous alternation task in T-maze. Cognitive deficits in lesioned aged rats were detected by a continuous alternation and delayed non-matching-to-sample tasks in T-maze. Adenovirus-mediated BDNF gene expression enhanced neuronal plasticity, as revealed by behavioral tests and LTP formation. Chronic administration of carnitine over time pre- and post-lesions seemed to partially ameliorate the cognitive deficits caused by the synaptic lesion. The carnitine-accelerated recovery from synaptic damage was observed by electron microscopy. These results demonstrate that the BoNTx-lesioned rat can be used as a model for dementia and that cognitive deficits can be alleviated in part by BDNF gene transfer or carnitine administration.


Assuntos
Doença de Alzheimer/fisiopatologia , Fator Neurotrófico Derivado do Encéfalo/farmacologia , Carnitina/farmacologia , Transtornos Cognitivos/fisiopatologia , Córtex Entorrinal/efeitos dos fármacos , Terminações Pré-Sinápticas/efeitos dos fármacos , Envelhecimento/metabolismo , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/patologia , Animais , Toxinas Botulínicas Tipo A/farmacologia , Fator Neurotrófico Derivado do Encéfalo/genética , Fator Neurotrófico Derivado do Encéfalo/uso terapêutico , Carnitina/uso terapêutico , Transtornos Cognitivos/tratamento farmacológico , Transtornos Cognitivos/patologia , Modelos Animais de Doenças , Córtex Entorrinal/patologia , Córtex Entorrinal/ultraestrutura , Vetores Genéticos/uso terapêutico , Potenciação de Longa Duração/efeitos dos fármacos , Potenciação de Longa Duração/fisiologia , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Aprendizagem em Labirinto/fisiologia , Proteínas de Membrana/antagonistas & inibidores , Proteínas de Membrana/metabolismo , Microscopia Eletrônica , Regeneração Nervosa/efeitos dos fármacos , Regeneração Nervosa/fisiologia , Terminações Pré-Sinápticas/patologia , Terminações Pré-Sinápticas/ultraestrutura , Proteínas R-SNARE , Ratos , Ratos Endogâmicos F344 , Proteínas Recombinantes de Fusão/farmacologia , Recuperação de Função Fisiológica/efeitos dos fármacos , Recuperação de Função Fisiológica/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...